Gross Profit Summary of Novo Nordisk A/S

Novo Nordisk A/S's latest annual gross profit in 2023 was 196.49 Billion DKK , up 32.32% from previous year.
Novo Nordisk A/S's latest quarterly gross profit in 2024 Q2 was 57.78 Billion DKK , up 4.24% from previous quarter.
Novo Nordisk A/S reported a annual gross profit of 148.5 Billion DKK in annual gross profit 2022, up 26.77% from previous year.
Novo Nordisk A/S reported a annual gross profit of 117.14 Billion DKK in annual gross profit 2021, up 10.5% from previous year.
Novo Nordisk A/S reported a quarterly gross profit of 55.43 Billion DKK for 2024 Q1, down -0.74% from previous quarter.
Novo Nordisk A/S reported a quarterly gross profit of 55.84 Billion DKK for 2023 Q4, up 13.94% from previous quarter.

Annual Gross Profit Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Gross Profit of Novo Nordisk A/S (2023 - 1989)

Year	Gross Profit	Gross Profit Growth
2023	196.49 Billion DKK	32.32%
2022	148.5 Billion DKK	26.77%
2021	117.14 Billion DKK	10.5%
2020	106.01 Billion DKK	4.0%
2019	101.93 Billion DKK	8.19%
2018	94.21 Billion DKK	0.16%
2017	94.06 Billion DKK	-0.56%
2016	94.59 Billion DKK	3.12%
2015	91.73 Billion DKK	23.56%
2014	74.24 Billion DKK	6.93%
2013	69.43 Billion DKK	7.54%
2012	64.56 Billion DKK	20.1%
2011	53.75 Billion DKK	9.49%
2010	49.09 Billion DKK	20.81%
2009	40.64 Billion DKK	14.37%
2008	35.53 Billion DKK	10.75%
2007	32.08 Billion DKK	10.02%
2006	29.16 Billion DKK	18.8%
2005	24.54 Billion DKK	16.19%
2004	21.12 Billion DKK	10.32%
2003	19.15 Billion DKK	3.36%
2002	18.52 Billion DKK	4.38%
2001	17.75 Billion DKK	8.01%
2000	16.43 Billion DKK	3.4%
1999	15.89 Billion DKK	17.54%
1998	13.52 Billion DKK	10.28%
1997	12.26 Billion DKK	14.21%
1996	10.73 Billion DKK	8.63%
1995	9.88 Billion DKK	2.06%
1994	9.68 Billion DKK	43.73%
1993	6.73 Billion DKK	-17.27%
1992	8.14 Billion DKK	61.78%
1991	5.03 Billion DKK	19.67%
1990	4.2 Billion DKK	9.15%
1989	3.85 Billion DKK	32.3%

Year	Gross Profit	Gross Profit Growth
2024 Q2	57.78 Billion DKK	4.24%
2024 Q1	55.43 Billion DKK	-0.74%
2023 Q4	55.84 Billion DKK	13.94%
2023 Q1	45.18 Billion DKK	13.44%
2023 FY	196.49 Billion DKK	32.32%
2023 Q3	49.01 Billion DKK	5.54%
2023 Q2	46.44 Billion DKK	2.79%
2022 Q1	35.11 Billion DKK	9.42%
2022 Q4	39.83 Billion DKK	3.82%
2022 Q3	38.36 Billion DKK	9.01%
2022 FY	148.5 Billion DKK	26.77%
2022 Q2	35.19 Billion DKK	0.23%
2021 Q1	27.99 Billion DKK	5.56%
2021 Q4	32.09 Billion DKK	8.55%
2021 Q3	29.56 Billion DKK	7.53%
2021 Q2	27.49 Billion DKK	-1.78%
2021 FY	117.14 Billion DKK	10.5%
2020 Q2	25.23 Billion DKK	-11.43%
2020 Q1	28.48 Billion DKK	5.57%
2020 FY	106.01 Billion DKK	4.0%
2020 Q4	26.51 Billion DKK	2.9%
2020 Q3	25.77 Billion DKK	2.13%
2019 Q3	25.2 Billion DKK	0.06%
2019 Q1	24.55 Billion DKK	-2.07%
2019 Q2	25.18 Billion DKK	2.56%
2019 Q4	26.98 Billion DKK	7.07%
2019 FY	101.93 Billion DKK	8.19%
2018 Q4	25.07 Billion DKK	7.42%
2018 Q3	23.34 Billion DKK	1.27%
2018 Q2	23.05 Billion DKK	1.42%
2018 Q1	22.73 Billion DKK	-2.4%
2018 FY	94.21 Billion DKK	0.16%
2017 FY	94.06 Billion DKK	-0.56%
2017 Q4	23.29 Billion DKK	4.25%
2017 Q3	22.34 Billion DKK	-7.79%
2017 Q2	24.22 Billion DKK	0.12%
2017 Q1	24.2 Billion DKK	-1.84%
2016 Q2	23.41 Billion DKK	1.9%
2016 Q1	22.97 Billion DKK	-5.32%
2016 FY	94.59 Billion DKK	3.12%
2016 Q3	23.55 Billion DKK	0.59%
2016 Q4	24.65 Billion DKK	4.68%
2015 FY	91.73 Billion DKK	23.56%
2015 Q3	22.94 Billion DKK	-1.1%
2015 Q1	21.32 Billion DKK	3.59%
2015 Q4	24.26 Billion DKK	5.77%
2015 Q2	23.2 Billion DKK	8.79%
2014 Q1	16.87 Billion DKK	-7.77%
2014 FY	74.24 Billion DKK	6.93%
2014 Q4	20.58 Billion DKK	9.37%
2014 Q3	18.82 Billion DKK	4.82%
2014 Q2	17.95 Billion DKK	6.41%
2013 FY	69.43 Billion DKK	7.54%
2013 Q3	16.98 Billion DKK	-4.43%
2013 Q1	16.37 Billion DKK	-8.06%
2013 Q2	17.77 Billion DKK	8.55%
2013 Q4	18.29 Billion DKK	7.72%
2012 FY	64.56 Billion DKK	20.1%
2012 Q3	16.36 Billion DKK	1.97%
2012 Q2	16.04 Billion DKK	11.82%
2012 Q1	14.34 Billion DKK	-4.33%
2012 Q4	17.8 Billion DKK	8.86%
2011 Q3	13.28 Billion DKK	2.94%
2011 FY	53.75 Billion DKK	9.49%
2011 Q4	14.99 Billion DKK	12.93%
2011 Q2	12.9 Billion DKK	2.59%
2011 Q1	12.57 Billion DKK	-3.55%
2010 Q2	12.42 Billion DKK	13.12%
2010 Q1	10.98 Billion DKK	5.34%
2010 Q4	13.03 Billion DKK	3.09%
2010 FY	49.09 Billion DKK	20.81%
2010 Q3	12.64 Billion DKK	1.79%
2009 Q4	10.42 Billion DKK	6.05%
2009 FY	40.64 Billion DKK	14.37%
2009 Q2	10.39 Billion DKK	4.01%
2009 Q1	9.99 Billion DKK	-1.67%
2009 Q3	9.83 Billion DKK	-5.38%
2008 FY	35.53 Billion DKK	10.75%
2008 Q2	8.55 Billion DKK	4.49%
2008 Q3	8.63 Billion DKK	0.84%
2008 Q4	10.15 Billion DKK	17.7%
2008 Q1	8.19 Billion DKK	-2.52%
2007 FY	32.08 Billion DKK	10.02%
2007 Q2	8.2 Billion DKK	9.5%
2007 Q3	7.98 Billion DKK	-2.69%
2007 Q4	8.4 Billion DKK	5.23%
2007 Q1	7.49 Billion DKK	-5.11%
2006 Q3	7.24 Billion DKK	-3.09%
2006 Q2	7.47 Billion DKK	14.38%
2006 FY	29.16 Billion DKK	18.8%
2006 Q4	7.89 Billion DKK	9.01%
2006 Q1	6.53 Billion DKK	-4.99%
2005 Q1	5.17 Billion DKK	-10.29%
2005 FY	24.54 Billion DKK	16.19%
2005 Q4	6.88 Billion DKK	6.97%
2005 Q3	6.43 Billion DKK	6.0%
2005 Q2	6.06 Billion DKK	17.19%
2004 Q3	5.37 Billion DKK	7.54%
2004 FY	21.12 Billion DKK	10.32%
2004 Q4	5.77 Billion DKK	7.29%
2004 Q2	5 Billion DKK	6.7%
2004 Q1	4.68 Billion DKK	-35.38%
2003 Q1	6.09 Billion DKK	-8.86%
2003 Q4	7.25 Billion DKK	8.07%
2003 Q3	6.71 Billion DKK	3.56%
2003 Q2	6.48 Billion DKK	6.45%
2003 FY	19.15 Billion DKK	3.36%
2002 FY	18.52 Billion DKK	4.38%
2002 Q2	5.27 Billion DKK	-12.32%
2002 Q1	6.02 Billion DKK	-7.42%
2002 Q3	6.44 Billion DKK	22.11%
2002 Q4	6.68 Billion DKK	3.67%
2001 Q2	5.74 Billion DKK	7.47%
2001 Q1	5.34 Billion DKK	146.84%
2001 FY	17.75 Billion DKK	8.01%
2001 Q4	6.5 Billion DKK	-2.24%
2001 Q3	6.65 Billion DKK	15.78%
2000 Q4	2.16 Billion DKK	-85.88%
2000 FY	16.43 Billion DKK	3.4%
2000 Q3	15.34 Billion DKK	136.62%
2000 Q2	6.48 Billion DKK	16.57%
2000 Q1	5.56 Billion DKK	0.01%
1999 Q1	4.63 Billion DKK	-5.0%
1999 FY	15.89 Billion DKK	17.54%
1999 Q4	5.56 Billion DKK	-4.48%
1999 Q3	5.82 Billion DKK	15.94%
1999 Q2	5.02 Billion DKK	8.45%
1998 FY	13.52 Billion DKK	10.28%
1998 Q2	4.56 Billion DKK	8.95%
1998 Q1	4.19 Billion DKK	-10.56%
1998 Q3	5.03 Billion DKK	10.22%
1998 Q4	4.87 Billion DKK	-3.17%
1997 Q3	4.31 Billion DKK	4.63%
1997 FY	12.26 Billion DKK	14.21%
1997 Q1	3.62 Billion DKK	-13.67%
1997 Q2	4.12 Billion DKK	13.72%
1997 Q4	4.68 Billion DKK	8.61%
1996 FY	10.73 Billion DKK	8.63%
1996 Q4	4.2 Billion DKK	14.51%
1996 Q3	3.66 Billion DKK	4.6%
1996 Q2	3.5 Billion DKK	2.12%
1996 Q1	3.43 Billion DKK	0.7%
1995 Q2	3.57 Billion DKK	6.01%
1995 Q1	3.37 Billion DKK	-5.24%
1995 Q3	3.21 Billion DKK	-9.94%
1995 FY	9.88 Billion DKK	2.06%
1995 Q4	3.41 Billion DKK	6.0%
1994 FY	9.68 Billion DKK	43.73%
1994 Q1	3.11 Billion DKK	-26.64%
1994 Q2	3.42 Billion DKK	10.02%
1994 Q3	3.37 Billion DKK	-1.4%
1994 Q4	3.55 Billion DKK	5.4%
1993 Q4	4.24 Billion DKK	35.46%
1993 Q1	2.62 Billion DKK	-3.24%
1993 Q2	3 Billion DKK	14.37%
1993 Q3	3.13 Billion DKK	4.25%
1993 FY	6.73 Billion DKK	-17.27%
1992 Q3	2.56 Billion DKK	-8.67%
1992 Q4	2.71 Billion DKK	5.79%
1992 Q2	2.8 Billion DKK	5.54%
1992 FY	8.14 Billion DKK	61.78%
1992 Q1	2.66 Billion DKK	-9.6%
1991 Q1	2.27 Billion DKK	-2.13%
1991 Q2	2.24 Billion DKK	-1.2%
1991 FY	5.03 Billion DKK	19.67%
1991 Q4	2.94 Billion DKK	23.05%
1991 Q3	2.39 Billion DKK	6.4%
1990 Q1	1.94 Billion DKK	-9.53%
1990 Q3	2.02 Billion DKK	-0.11%
1990 FY	4.2 Billion DKK	9.15%
1990 Q4	2.32 Billion DKK	14.61%
1990 Q2	2.03 Billion DKK	4.7%
1989 Q3	1.74 Billion DKK	-0.53%
1989 Q1	1.97 Billion DKK	20.78%
1989 FY	3.85 Billion DKK	32.3%
1989 Q4	2.14 Billion DKK	22.72%
1989 Q2	1.75 Billion DKK	-11.07%

Peer Gross Profit Comparison of Novo Nordisk A/S

Name	Gross Profit	Gross Profit Difference
ADC Therapeutics SA	67.02 Million USD	-293050.726%
Alto Neuroscience, Inc.	-373 Thousand USD	52679992.761%
Annovis Bio, Inc.	- USD	-Infinity%
Biohaven Pharmaceutical Holding Company Ltd.	-3.36 Million USD	5832572.544%
Ginkgo Bioworks Holdings, Inc.	197.45 Million USD	-99416.84%
Nuvation Bio Inc.	-222 Thousand USD	88511811.712%
Nuvation Bio Inc.	-222 Thousand USD	88511811.712%
Arcus Biosciences, Inc.	-223 Million USD	88214.798%
Theriva Biologics, Inc.	-135 Thousand USD	145552692.593%
Zymeworks Inc.	-66.97 Million USD	293478.324%

Global Stocks Search

Novo Nordisk A/S (NVO)

Gross Profit Summary of Novo Nordisk A/S

Annual Gross Profit Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Gross Profit of Novo Nordisk A/S (2023 - 1989)

Peer Gross Profit Comparison of Novo Nordisk A/S